Home > Journals > Indian Journal of Cancer Education and Research

Indian Journal of Cancer Education and Research

Submit your article Read this Journals View all journals
Full Text (PDF)
Editorial

Hypoxia-Inducible Factors: Novel Molecular Target Remains to be Explored as Anticancer Agent in Advanced Human Cancers

Thekkuttuparambil A. Ajith , Thekkuttuparambil A. Ajith

Author Information

Licence:



Indian Journal of Cancer Education and Research 5(1):p 5-7, January - June 2017. | DOI: N/A

How Cite This Article:

Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

Hypoxia-inducible factors (HIFs) are transcription factors that are expressed as cellular adaptations in order to improve the metabolism as well as neovascularisation in the hypoxic tumor microenvironment. HIFs induce the expression of various genes of proteins such as vascular endothelial growth factors and plateletderived growth factors that have a central pivotal role in the angiogenesis and inflammation. Accounting the role played by HIFs, many recent studies highlighted the significance of therapeutic potential of HIF-targeted antagonists. Agents that block the nuclear localization of HIF-1alpha or that which inhibits the dimerization of HIF-1, or the one that inhibits the HIF-1alpha/HIF-2alpha mediated induction of VEGF were demonstrated as effective antiangiogenic agents in advanced cancers. This short communication describes a recent highlight on the need of targeting the HIFs.

Keywords: Hypoxia-Inducible Factor; Antagonists; Clear Cell Renal Cell Carcinoma; Angiogenesis; Hypoxia; Normoxia.

References

No records found.


About this article

Cite this article

Licence:



Received Accepted Published
N/A N/A N/A
DOI: N/A

Keywords


Article Level Metrics

Last Updated

Friday 31 July 2026, 15:26:41 (IST)

1318

Accesses

3
266
00

Citations


NA
NA
NA

Download citation


Article Keywords

Keyword Highlighting

Highlight selected keywords in the article text.


Timeline

Received N/A
Accepted N/A
Published N/A

licence




Access this article

Reprint Order Form
Buy this Article
Institutional Subscriptions

Share